ATP6V1B1
Basic information
Region (hg38): 2:70935900-70965431
Previous symbols: [ "VPP3", "ATP6B1" ]
Links
Phenotypes
GenCC
Source:
- autosomal recessive distal renal tubular acidosis (Supportive), mode of inheritance: AR
- renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Definitive), mode of inheritance: AR
- renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Strong), mode of inheritance: AR
- renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Definitive), mode of inheritance: AR
- renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Strong), mode of inheritance: AR
- renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss | AR | Renal | Individuals can present in infancy with acute with dehydration (which can be lethal), which can be prevented by early recognition | Audiologic/Otolaryngologic; Renal | 9916796; 12414817; 12566520; 16433694; 18798332 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (58 variants)
- Renal tubular acidosis with progressive nerve deafness (18 variants)
- Distal renal tubular acidosis (3 variants)
- Nephrocalcinosis;Nephrolithiasis (1 variants)
- ATP6V1B1-related disorder (1 variants)
- Inborn genetic diseases (1 variants)
- Renal tubular acidosis (1 variants)
- Rare genetic deafness (1 variants)
- Polydactyly, postaxial, type A1;Nephrocalcinosis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP6V1B1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 207 | 216 | ||||
missense | 110 | 123 | ||||
nonsense | 18 | 25 | ||||
start loss | 2 | |||||
frameshift | 31 | 38 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 17 | 24 | ||||
splice region | 3 | 42 | 45 | |||
non coding | 119 | 34 | 158 | |||
Total | 59 | 35 | 121 | 329 | 43 |
Highest pathogenic variant AF is 0.0000263
Variants in ATP6V1B1
This is a list of pathogenic ClinVar variants found in the ATP6V1B1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-70935921-C-T | Renal tubular acidosis with progressive nerve deafness • not specified | Benign (Jul 10, 2021) | ||
2-70935936-C-T | Renal tubular acidosis with progressive nerve deafness | Conflicting classifications of pathogenicity (Jun 01, 2018) | ||
2-70935938-C-T | Renal tubular acidosis with progressive nerve deafness • ATP6V1B1-related disorder | Likely benign (Jul 20, 2020) | ||
2-70935955-A-C | Renal tubular acidosis with progressive nerve deafness | Uncertain significance (Mar 21, 2022) | ||
2-70935956-T-C | not specified • Renal tubular acidosis with progressive nerve deafness | Benign (Feb 01, 2024) | ||
2-70935957-G-A | Uncertain significance (Feb 02, 2024) | |||
2-70935958-G-T | Renal tubular acidosis with progressive nerve deafness • Inborn genetic diseases | Uncertain significance (Jan 10, 2023) | ||
2-70935959-C-A | not specified • Renal tubular acidosis with progressive nerve deafness | Uncertain significance (Feb 20, 2015) | ||
2-70935960-C-G | Likely benign (Jul 25, 2023) | |||
2-70935960-C-T | Renal tubular acidosis with progressive nerve deafness | Likely benign (Sep 30, 2023) | ||
2-70935972-C-G | Uncertain significance (May 24, 2022) | |||
2-70935972-C-T | Likely benign (Sep 29, 2022) | |||
2-70935978-G-GC | Pathogenic (Oct 23, 2021) | |||
2-70935980-CT-C | Pathogenic (Jan 11, 2024) | |||
2-70935981-T-C | not specified • Renal tubular acidosis with progressive nerve deafness | Benign (Feb 01, 2024) | ||
2-70935981-TG-C | Renal tubular acidosis with progressive nerve deafness | Pathogenic/Likely pathogenic (Dec 22, 2021) | ||
2-70935981-TG-T | Pathogenic (Sep 29, 2021) | |||
2-70935981-T-TG | Renal tubular acidosis with progressive nerve deafness | Pathogenic (Jan 09, 2024) | ||
2-70935984-G-A | Likely benign (Mar 01, 2023) | |||
2-70935987-G-A | Likely benign (Oct 04, 2023) | |||
2-70935987-G-C | Renal tubular acidosis with progressive nerve deafness | Conflicting classifications of pathogenicity (Jan 05, 2024) | ||
2-70935990-C-A | Likely benign (Jun 09, 2023) | |||
2-70935990-C-T | Likely benign (Aug 25, 2023) | |||
2-70935993-C-T | Likely benign (Jan 31, 2024) | |||
2-70935994-G-A | not specified • Renal tubular acidosis with progressive nerve deafness | Benign/Likely benign (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATP6V1B1 | protein_coding | protein_coding | ENST00000234396 | 14 | 29525 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.40e-9 | 0.890 | 125700 | 0 | 48 | 125748 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.232 | 297 | 308 | 0.963 | 0.0000199 | 3344 |
Missense in Polyphen | 108 | 124.02 | 0.87085 | 1300 | ||
Synonymous | 0.373 | 121 | 126 | 0.958 | 0.00000875 | 1025 |
Loss of Function | 1.77 | 18 | 28.2 | 0.639 | 0.00000170 | 291 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000423 | 0.000423 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000294 | 0.000294 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Non-catalytic subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells.;
- Disease
- DISEASE: Renal tubular acidosis, distal, with progressive nerve deafness (dRTA-D) [MIM:267300]: An autosomal recessive disease characterized by the association of renal distal tubular acidosis with sensorineural hearing loss. Distal renal tubular acidosis is characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha- intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. {ECO:0000269|PubMed:12414817, ECO:0000269|PubMed:12579397, ECO:0000269|PubMed:9916796}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human);Synaptic vesicle cycle - Homo sapiens (human);Phagosome - Homo sapiens (human);Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Collecting duct acid secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Signal Transduction;Transferrin endocytosis and recycling;Ion channel transport;Insulin receptor recycling;Signaling by Insulin receptor;ROS, RNS production in phagocytes;Purine metabolism;Innate Immune System;Immune System;Transport of small molecules;Iron uptake and transport;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.324
Intolerance Scores
- loftool
- 0.264
- rvis_EVS
- -0.48
- rvis_percentile_EVS
- 22.75
Haploinsufficiency Scores
- pHI
- 0.166
- hipred
- Y
- hipred_score
- 0.578
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.692
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Atp6v1b1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype; homeostasis/metabolism phenotype; taste/olfaction phenotype;
Gene ontology
- Biological process
- ossification;regulation of pH;excretion;sensory perception of sound;insulin receptor signaling pathway;ATP hydrolysis coupled proton transport;regulation of macroautophagy;transferrin transport;ion transmembrane transport;inner ear morphogenesis;pH reduction;ATP metabolic process;calcium ion homeostasis;proton transmembrane transport
- Cellular component
- cytoplasm;cytosol;microvillus;basolateral plasma membrane;apical plasma membrane;lateral plasma membrane;vacuolar proton-transporting V-type ATPase complex;proton-transporting V-type ATPase, V1 domain;extracellular exosome;extrinsic component of synaptic vesicle membrane
- Molecular function
- ATP binding;proton transmembrane transporter activity;hydrolase activity;protein-containing complex binding